Zullo Investment Group Inc. Has $255,000 Stock Holdings in Colgate-Palmolive (NYSE:CL)

Zullo Investment Group Inc. trimmed its stake in Colgate-Palmolive (NYSE:CLGet Rating) by 10.6% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,358 shares of the company’s stock after selling 397 shares during the quarter. Zullo Investment Group Inc.’s holdings in Colgate-Palmolive were worth $255,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Vanguard Group Inc. lifted its stake in shares of Colgate-Palmolive by 0.6% in the first quarter. Vanguard Group Inc. now owns 77,195,703 shares of the company’s stock valued at $5,853,750,000 after buying an additional 449,089 shares in the last quarter. BlackRock Inc. lifted its stake in shares of Colgate-Palmolive by 2.1% in the first quarter. BlackRock Inc. now owns 66,575,004 shares of the company’s stock valued at $5,048,384,000 after buying an additional 1,356,519 shares in the last quarter. State Street Corp lifted its stake in shares of Colgate-Palmolive by 1.6% in the fourth quarter. State Street Corp now owns 49,282,107 shares of the company’s stock valued at $4,205,735,000 after buying an additional 753,469 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of Colgate-Palmolive by 4.8% in the fourth quarter. Geode Capital Management LLC now owns 15,342,882 shares of the company’s stock valued at $1,306,535,000 after buying an additional 707,482 shares in the last quarter. Finally, Northern Trust Corp lifted its stake in shares of Colgate-Palmolive by 0.5% in the first quarter. Northern Trust Corp now owns 10,470,409 shares of the company’s stock valued at $793,971,000 after buying an additional 50,040 shares in the last quarter. 78.62% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Colgate-Palmolive

In related news, CEO Noel R. Wallace sold 51,665 shares of the business’s stock in a transaction that occurred on Thursday, August 4th. The shares were sold at an average price of $81.27, for a total transaction of $4,198,814.55. Following the completion of the transaction, the chief executive officer now owns 221,790 shares of the company’s stock, valued at $18,024,873.30. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In other news, CEO Noel R. Wallace sold 51,665 shares of the business’s stock in a transaction that occurred on Thursday, August 4th. The shares were sold at an average price of $81.27, for a total value of $4,198,814.55. Following the completion of the sale, the chief executive officer now directly owns 221,790 shares in the company, valued at approximately $18,024,873.30. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Prabha Parameswaran sold 48,778 shares of the business’s stock in a transaction that occurred on Monday, August 29th. The stock was sold at an average price of $78.80, for a total transaction of $3,843,706.40. Following the completion of the sale, the insider now owns 6,787 shares of the company’s stock, valued at $534,815.60. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 125,146 shares of company stock valued at $10,049,640. Corporate insiders own 0.32% of the company’s stock.

Colgate-Palmolive Price Performance

CL opened at $78.03 on Friday. The company has a market capitalization of $65.09 billion, a price-to-earnings ratio of 33.78, a PEG ratio of 5.57 and a beta of 0.48. The company has a quick ratio of 0.72, a current ratio of 1.17 and a debt-to-equity ratio of 14.26. The firm has a 50-day moving average price of $79.53 and a 200-day moving average price of $78.13. Colgate-Palmolive has a twelve month low of $72.20 and a twelve month high of $85.61.

Colgate-Palmolive (NYSE:CLGet Rating) last issued its quarterly earnings data on Friday, July 29th. The company reported $0.72 EPS for the quarter, beating the consensus estimate of $0.71 by $0.01. The company had revenue of $4.48 billion during the quarter, compared to analysts’ expectations of $4.35 billion. Colgate-Palmolive had a net margin of 10.98% and a return on equity of 315.10%. Colgate-Palmolive’s revenue for the quarter was up 5.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.80 earnings per share. Equities analysts expect that Colgate-Palmolive will post 3.03 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 15th. Investors of record on Friday, October 21st will be paid a dividend of $0.47 per share. This represents a $1.88 annualized dividend and a yield of 2.41%. Colgate-Palmolive’s dividend payout ratio is currently 81.39%.

Analyst Ratings Changes

CL has been the topic of a number of recent research reports. JPMorgan Chase & Co. dropped their price objective on shares of Colgate-Palmolive from $79.00 to $78.00 in a research note on Thursday, July 21st. Barclays raised their price target on shares of Colgate-Palmolive from $71.00 to $74.00 and gave the company an “equal weight” rating in a research report on Tuesday, August 2nd. StockNews.com raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Tuesday, August 2nd. Deutsche Bank Aktiengesellschaft dropped their price target on shares of Colgate-Palmolive from $88.00 to $87.00 in a research report on Tuesday, July 19th. Finally, Wells Fargo & Company raised shares of Colgate-Palmolive to an “equal weight” rating in a research report on Tuesday, August 9th. Twelve analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $84.57.

Colgate-Palmolive Profile

(Get Rating)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.